Prognozy (mln) dla Zylox-Tonbridge Medical Technology Co., Ltd.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
843.91 |
1,168.65 |
1,544.03 |
1,999.03 |
| Przychód Δ r/r |
0.00% |
38.48% |
32.12% |
29.47% |
| Przychód (min) |
833.05 |
1,150.12 |
1,461.00 |
1,931.15 |
| Przychód (max) |
853.93 |
1,182.81 |
1,615.14 |
2,066.91 |
| EBITDA (średnia) |
-380.52 |
-526.94 |
-696.20 |
-901.36 |
| EBIT (średnia) |
-411.54 |
-569.91 |
-752.96 |
-974.85 |
| EBIT % |
-48.77% |
-48.77% |
-48.77% |
-48.77% |
| Zysk netto (średni) |
100.26 |
156.50 |
231.00 |
332.50 |
| Zysk netto % |
11.88% |
13.39% |
14.96% |
16.63% |
| EPS (średnia) |
0.31 |
0.49 |
0.73 |
1.06 |
| Liczba analityków (Przychody) |
4 |
3 |
4 |
3 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
2 |
| symbol |
2190.HK |
2190.HK |
2190.HK |
2190.HK |